Dougados, Maxime <br/><br/>
Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitis.  [electronic resource] 

 -  Arthritis care & research  Feb 2012 
 - 290-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2151-4658 
<br/><br/><label>Standard No.: </label>10.1002/acr.20671  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Drug Administration Schedule<br/>Drug Monitoring--methods<br/>Drug Utilization--statistics & numerical data<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Male<br/>Middle Aged<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Spondylitis, Ankylosing--drug therapy